Successfully reported this slideshow.

Biomarkers in interstitial lung diseases: is it possible to monitor and better treat the patients?

1 of 20
1 of 20

More Related Content

Related Books

Free with a 30 day trial from Scribd

See all

Related Audiobooks

Free with a 30 day trial from Scribd

See all

Biomarkers in interstitial lung diseases: is it possible to monitor and better treat the patients?

  1. 1. SESSION III: Biomarkers in interstitial lung diseases: is it possible to monitor and better treat the patients? BRN Seminar: BIOMARKERS IN RESPIRATORY DISEASES Dr. Jacob Sellarés, MD • Interstitial Lung Disease Program Director, Servei de Pneumologia, Institut Clínic Respiratori (ICR), Hospital Clinic, Barcelona • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona.
  2. 2. Am J Respir Crit Care Med Vol 198, Iss 5, pp e44–e68, Sep 1, 2018
  3. 3. Biomarkers in interstitial lung diseases: is it possible to monitor and better treat the patients? The answer is NO, IT IS NOT POSSIBLE
  4. 4. THE END OF BIOMARKERS IN ILDs? My last submitted grant: The strategic objective of this project is the translational nature and consists of identifying new biomarkers associated with the clinical and biological heterogeneity of ILDs to stratify patients on solid physiopathological bases and thus advance towards the treatment of disease accuracy.
  5. 5. Biomarkers a) Risk or predisposition b) Diagnostic c) Pronostic d) Therapeutic
  6. 6. Problems • Difiiculties: • To define their role in Guidelines • Clinical application • Expensive • Slow • Heterogeneity • Only one biomarker? • Better than other markers?: • Functional: FVC • Radiological
  7. 7. Biomarkers in interstitial lung diseases: is it possible to monitor and better treat the patients? The answer is NO, IT IS NOT POSSIBLE with the current ones, but in the future….
  8. 8. sellares@clinic.cat pneumompid@clinic.cat Muchas Gracias ¡¡¡¡Muchas gracias!!!

×